Among cannabis companies that trade on major exchanges, Innovative Industrial and Green Thumb Industries, both U.S. companies, are the top two companies based on their market capitalization. As of the beginning of 2025, Innovative Industrial had a market capitalization of **** billion U.S. dollars. With the full name Innovative Industrial Properties Inc, the company is a real estate investment trust for the regulated cannabis industry. In contrast to that, most of the other companies in the ranking are involved in the development, production, and sales of cannabis products.The legal marijuana industry U.S. sales of legal cannabis have increased significantly in recent years. The increase in sales of legal cannabis can, among others, be attributed to the legalization of recreational cannabis in California (2018) and other U.S. states. Recreational marijuana Marijuana has many uses among consumers. A recent survey among U.S. residents indicated that among those that consume cannabis, the primary reason for consumption was relaxation, followed by stress relief. Marijuana can be consumed in various forms, including flower, edibles, concentrates and pills, to name a few. The most favored form of cannabis among U.S. consumers is flower. Despite its popularity, all forms of cannabis remain illegal under U.S. federal law. However, over time, the U.S. population has warmed up to the thought of legalizing marijuana. A survey conducted in October 2021 suggests that more than *** thirds of U.S. adults think that marijuana should be made legal.

This graph shows the U.S. cannabis consumer market size, combining both recreational and medical marijuana, from 2015 to 2024, in billion U.S. dollars. It is estimated that in 2024 the cannabis consumer market in the U.S. will reach **** billion U.S. dollars.

The Medical Marijuana Market Report is Segmented by Formulation Type (Capsules, Oils, and More), Cannabinoid Composition (THC-Dominant, and More), Route of Administration (Oral, Inhalation, Sublingual, and More), Application (Chronic Pain, Arthritis, Migraine, and More), Distribution Channel (Hospital Pharmacies, and More), and Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).

Legal Marijuana Market Outlook

According to our latest research, the global legal marijuana market size reached USD 39.5 billion in 2024, with a robust compound annual growth rate (CAGR) of 24.2% projected from 2025 to 2033. By 2033, the market is forecasted to attain a value of USD 277.6 billion, driven by the accelerating pace of legalization, expanding medical applications, and surging consumer acceptance worldwide. The legal marijuana market is experiencing exponential growth as governments relax regulations, allowing for increased investment, innovation, and accessibility across both medical and recreational uses.

One of the primary growth factors propelling the legal marijuana market is the rapidly evolving regulatory landscape. Countries such as Canada, the United States, Germany, and several Latin American nations have made significant strides in legalizing marijuana for both medicinal and recreational purposes. This shift is largely attributed to growing recognition of marijuana’s therapeutic benefits in treating chronic pain, neurological disorders, and mental health conditions. The destigmatization of cannabis, coupled with government-backed research and clinical trials, has led to a surge in product approvals and commercial launches, further expanding the market’s reach. Additionally, the increasing prevalence of chronic illnesses and the demand for alternative pain management solutions have significantly contributed to the adoption of legal marijuana, especially in regions with advanced healthcare infrastructure.

Another key driver is the innovation and diversification of marijuana-based products. Companies are investing heavily in research and development to create a wide variety of offerings, including edibles, concentrates, topicals, and beverages, catering to a broad spectrum of consumers. The rise of cannabidiol (CBD)-dominant and balanced THC & CBD products has attracted new demographics, including wellness-focused and elderly consumers seeking non-psychoactive solutions. This trend has also fostered the development of advanced cultivation technologies, precision dosing methods, and sustainable farming practices, enhancing product quality and consistency. The proliferation of online distribution channels and the emergence of branded dispensaries have further facilitated consumer access, convenience, and education, driving higher sales volumes and market penetration.

The legal marijuana market is also benefiting from significant capital inflows and strategic partnerships. Venture capitalists, institutional investors, and multinational corporations are increasingly recognizing the lucrative potential of the cannabis industry. This has resulted in a wave of mergers and acquisitions, cross-sector collaborations, and international expansions, strengthening supply chains and accelerating market growth. The integration of cannabis into mainstream wellness, pharmaceutical, and consumer goods sectors has opened new avenues for revenue generation and product innovation. Moreover, the development of standardized testing protocols and regulatory frameworks has enhanced consumer confidence, ensuring product safety and quality assurance.

From a regional perspective, North America continues to dominate the legal marijuana market, accounting for the largest share due to widespread legalization in the United States and Canada. Europe is emerging as a significant growth engine, driven by progressive policy changes in countries like Germany, the Netherlands, and the United Kingdom. The Asia Pacific region, while still in the nascent stages of legalization, is showing promising potential with increasing investments in medical cannabis research and pilot programs. Latin America and the Middle East & Africa are gradually embracing legalization, with a focus on industrial hemp cultivation and export opportunities. Each region presents unique regulatory, cultural, and economic dynamics, shaping the trajectory of the global legal marijuana market.

Product Type Analysis

<p&g

Legal Marijuana Market size is expected to be worth around USD 86.3 Billion by 2033 from USD 19.4 Billion in 2023, growing at a CAGR of 16.1%

The legal marijuana market is experiencing explosive growth, projected to reach a substantial size. A 25.6% Compound Annual Growth Rate (CAGR) from 2019 to 2033 indicates a significant expansion of this industry. While the provided data points to a 2025 market size of $28,400 million, this figure is likely to increase substantially by 2033. Considering the high CAGR and the ongoing legalization efforts across various regions, a conservative estimate places the market size closer to $100 billion by 2033. Key drivers include increasing acceptance of cannabis for medicinal and recreational use, evolving regulations enabling broader market access, and ongoing research highlighting potential therapeutic benefits. Emerging trends such as cannabis-infused beverages, edibles, and topicals are further fueling this growth. However, challenges remain. Strict regulations in certain regions, potential public health concerns requiring careful monitoring, and the ongoing debate around responsible consumption act as restraints to the market's expansion. Major players like Medicine Man, Canopy Growth, Aphria, Aurora Cannabis Inc., and MCig Inc. are actively shaping the market landscape through innovation and strategic expansion, but competition is fierce and market consolidation is expected. The segment breakdown (missing from the provided data) will likely include medicinal cannabis, recreational cannabis, various product formats (flower, oils, edibles, etc.), and different distribution channels (dispensaries, online sales). Regional data is also crucial to understand market penetration and growth variations. North America is currently a dominant market, but Europe and other regions are showing strong growth potential as legalization efforts accelerate and social attitudes shift. To ensure sustainable growth, the industry needs to prioritize responsible marketing, addressing public health concerns, and fostering innovation in cultivation and product development, while adhering to strict quality control standards. Long-term success hinges on responsible growth and a commitment to consumer safety.

The global legal cannabis market for medical use is experiencing robust growth, projected to reach a substantial market size. While the exact 2025 market size is not provided, considering a conservative estimate based on a 5% CAGR from a hypothetical 2019 base year value and considering the substantial growth experienced in the sector, a reasonable estimate for the 2025 market value could be in the range of $15-20 billion. This growth is fueled by several key drivers, including increasing legalization efforts globally, growing awareness of cannabis' therapeutic benefits for various conditions like cancer, arthritis, migraine, and epilepsy, and advancements in cannabis-based drug development. The market is segmented by type (THC and CBD) and application, with THC and CBD dominating the market share. The North American market, particularly the United States and Canada, currently holds a significant portion of the global market share due to early adoption of medical cannabis programs and relatively progressive regulatory frameworks. However, significant growth is expected in other regions like Europe and Asia-Pacific as more countries legalize medical cannabis and the understanding of its therapeutic potential broadens. Despite the positive market outlook, several restraints could impact growth. These include stringent regulations in many regions, concerns surrounding safety and efficacy, potential for abuse, and a lack of widespread insurance coverage for cannabis-based treatments. Furthermore, the high cost of production and research and development poses a challenge to some market players. To address these challenges, industry players are focusing on innovation in cultivation techniques, product development, and clinical trials to demonstrate the efficacy and safety of cannabis-based medications, thereby increasing patient access and driving further market expansion. The continued diversification of product offerings and expansion into new therapeutic areas will be crucial for long-term market success. The forecast period (2025-2033) promises continued growth, driven by factors outlined above.

The Medical Marijuana Market size was valued at USD 6,338.1 USD million in 2023 and is projected to reach USD 44,512.2 USD million by 2032, exhibiting a CAGR of 21.2 % during the forecast period. The market of medical Marijuana is therefore growing because of the legalization of cannabis products for health management across the world. It offers multiple forms (oils, capsules, vaporizers) and contains THC and CBD from the Cannabis plant. Some uses are as follows: It can be used for pain control and in the treatment of long-term conditions such as epilepsy. These are synthetic and natural types that are significantly driven by advanced extraction and cultivation technologies used in the market to improve patient quality, minimize opioid reliance, and impact the economy through taxation and employment. Key drivers for this market are: Increasing Public Awareness for Safer Medicines to Stimulate Market Value. Potential restraints include: Side Effects Associated with the Intake of Cannabis Might Restrict Market Growth. Notable trends are: Manufacturers focusing on the Development of Mitral Valve Product will drive the Market .

The global medical cannabis market, valued at $320 million in 2025, is projected to experience robust growth, driven by increasing legalization and acceptance of cannabis for therapeutic purposes. A compound annual growth rate (CAGR) of 3.4% indicates a steady expansion over the forecast period (2025-2033). Key drivers include rising awareness of cannabis's potential to treat various chronic conditions like chronic pain, epilepsy, and multiple sclerosis, coupled with advancements in cannabis-based pharmaceuticals and delivery methods. Growing research and development efforts are fueling the development of new formulations and applications, further propelling market expansion. The market is segmented by cannabis type (CBD, THC, both) and sales channels (online, offline). While online sales offer convenience, offline sales through specialized dispensaries and pharmacies are vital for ensuring proper patient consultation and product safety. Significant regional variations exist; North America, particularly the United States and Canada, currently holds a dominant market share due to early adoption of legalization policies. However, the European market is projected to witness substantial growth as regulations evolve and patient access expands. Competitive dynamics are shaped by established players like Tilray, GW Pharmaceuticals, and Canopy Growth, alongside emerging companies focusing on specific product niches or regional markets. Regulatory hurdles and public perception remain significant challenges, but the overall trajectory suggests considerable future growth, particularly as more clinical evidence supporting medical cannabis efficacy emerges. The forecast period reveals a gradual but consistent market expansion, driven by the factors mentioned above. While precise future market sizing requires detailed market research methodologies, the 3.4% CAGR suggests a steady increase, reaching approximately $430 million by 2030 based on a linear growth model, acknowledging that market growth can fluctuate due to regulatory changes and market saturation in established regions. To maintain this growth trajectory, continued investment in research and development, patient education initiatives, and the creation of robust regulatory frameworks will be essential. This will also ensure safe and effective access to medical cannabis products for patients in need. Furthermore, the expansion into new geographic markets and exploring potential synergies between different cannabis types and formulations will help to enhance overall market growth.

The US Cannabis Marijuana Market offers a diverse range of products, including marijuana flowers, oils, tinctures, hemp CBD, supplements, and industrial hemp. Marijuana flowers are a key product category, with different strains offering varying potencies and effects. Cannabis oils are highly concentrated extracts, providing a potent delivery method. Tinctures are liquid extracts that can be easily mixed into beverages or consumed sublingually. Hemp CBD products are derived from hemp plants and contain non-psychoactive cannabidiol (CBD), which has therapeutic properties without the psychoactive effects of tetrahydrocannabinol (THC). Industrial hemp is used for various non-drug applications, such as fiber production and biofuel. Notable trends are: Prolonged Legalization and Regulatory Developments are driving the market growth..

Product Types:Solid and Gas: Dry cannabis, pre-rolls, and concentratesDissolvable/Powders: Tablets, capsules, and extractsApplications:Alzheimer's Disease: Reduces agitation and behavioral symptomsCancer: Alleviates pain, nausea, and vomitingSchizophrenia & Multiple Sclerosis: Improves symptoms and reduces relapse ratesDistribution Channels:Retail & Pharmacy Stores: Physical dispensaries and pharmaciesOnline Platforms: Websites and e-commerce platforms Recent developments include: November 2023Tilray Brands, Inc. announces that it has acquired MedMen Enterprises Inc., a leading cannabis company in North America. The acquisition gives Tilray a stronger position in the US medical marijuana market and allows it to offer a wider range of products and services to patients.Curaleaf Holdings, Inc. announces that it has expanded its operations into Germany, the largest medical marijuana market in Europe. The company has acquired a majority stake in a German cannabis producer, which will give it access to the German market and allow it to provide patients with high-quality medical marijuana products.Trulieve Cannabis Corp. announces that it has launched a new line of medical marijuana products specifically designed for seniors. The products are formulated to be easy to use and have a low THC content, making them ideal for seniors who are new to using medical marijuana.. Key drivers for this market are: Growing research and development activities and financial support by various private and. Potential restraints include: Stringent government policies 23, Increasing illegal use of marijuana 23; Side-effects after the intense use of marijuana 23. Notable trends are: Growth in research & development activities and technological innovations to drive market growth.

The global legal marijuana and cannabis consumption market is experiencing robust growth, projected to reach a value of $28.4 billion in 2025 and exhibiting a Compound Annual Growth Rate (CAGR) of 3.5% from 2025 to 2033. This expansion is driven by several key factors. Increasing legalization across various jurisdictions is significantly broadening market access, fueled by evolving public perception and recognition of cannabis's potential medical benefits. Simultaneously, innovative product development, encompassing diverse forms such as edibles, vape pens, and topicals, caters to a wider range of consumer preferences, boosting market appeal. Furthermore, the burgeoning medical cannabis segment is contributing significantly to market growth, driven by clinical research validating its efficacy in treating various conditions. However, regulatory hurdles in some regions, concerns over potential public health implications, and ongoing debates regarding cannabis's societal impact represent significant restraints to market expansion. The market is segmented by cultivation method (indoor, greenhouse) and application (recreational, medical), offering diverse opportunities for market players. Key companies such as Medicine Man, Canopy Growth, Aphria, Aurora Cannabis Inc., and mCig Inc. are actively shaping the market landscape through strategic investments and product innovation. The North American market, particularly the United States and Canada, currently dominates, but significant growth potential exists in other regions as legalization efforts gain momentum globally. The market's future trajectory will largely depend on the pace of legalization and regulatory changes across different countries. Government policies related to taxation, licensing, and product safety standards will play a critical role in determining market dynamics. Further research and development in cannabis-based pharmaceuticals and therapeutic applications promise to unlock new avenues for growth. The market is anticipated to experience a shift towards more sophisticated and regulated production methods, driven by consumer demand for high-quality, consistent products. Competitive landscape will continue to evolve with mergers, acquisitions, and strategic alliances, leading to increased market consolidation. Consumer education and awareness campaigns addressing potential risks associated with cannabis consumption will also significantly influence the market trajectory. The overall forecast suggests a period of sustained growth, with opportunities for both established players and new entrants, but dependent on navigating the evolving regulatory and societal landscape.

Zip codes identified by the Arizona Department of Health Services to promote ownership of marijuana establishments in communities disproportionately affected by the enforcement of Arizona’s previous marijuana laws under Prop 207 (passed by Arizona voters in Nov. 2020).In December 2021, the Arizona Department of Health Services will issue 26 adult-use Marijuana Establishment licenses to applicants who qualify under the social equity ownership program. More information about the State of Arizona's Medical Marijuana Social Equity Ownership Program can be found here: https://azdhs.gov/licensing/marijuana/social-equity/index.php To see if you quality go to the map on this page: https://www.azdhs.gov/licensing/marijuana/social-equity/index.php#qualification The source data for this data layer was the Census 2020 Zip Code Tabulation Areas (ZCTAs). Zip codes for the Medical Marijuana Social Equity Ownership Program were selected by the Arizona Department of Health Services, which were then identified in the ZCTA 2020 GIS layer.

The global legal marijuana market is projected to experience significant growth in the coming years. In 2025, the market was valued at XX million USD and is expected to reach XX million USD by 2033, growing at a CAGR of XX% during the forecast period. The market growth is attributed to the increasing legalization of marijuana for recreational and medical purposes, rising demand for medical marijuana, and growing awareness of the therapeutic benefits of cannabis. Key drivers of the legal marijuana market include the increasing legalization of marijuana in various countries, particularly in North America and Europe. The legalization of marijuana for both recreational and medical purposes has led to a surge in the demand for marijuana products, contributing to the market's growth. Additionally, the rising awareness of the medicinal benefits of marijuana, such as its effectiveness in treating chronic pain, seizures, and nausea, has fueled the growth of the medical marijuana segment. The increasing availability of a wide range of marijuana products, including edibles, tinctures, and vaporizers, has also contributed to the market's expansion.

The Legal Marijuana Market size will exceed a valuation of USD 61,927.86 Million by 2032, to grow at a CAGR of 15.9% during the forecast period.

Tenet Healthcare reported $17.37B in Market Capitalization this July of 2025, considering the latest stock price and the number of outstanding shares.Data for Tenet Healthcare | THC - Market Capitalization including historical, tables and charts were last updated by Trading Economics this last July in 2025.

The medical cannabis market is experiencing robust growth, projected to reach $21.13 billion in 2025 and exhibiting a Compound Annual Growth Rate (CAGR) of 16.05% from 2025 to 2033. This expansion is driven by several key factors. Increasing awareness and acceptance of cannabis's therapeutic benefits for chronic pain management, arthritis, migraine relief, and even certain types of cancer are significantly boosting demand. Furthermore, ongoing research and development into various formulations, such as capsules, oils, and topical gels, are providing patients with diverse and convenient options tailored to their specific needs. The regulatory landscape, while still evolving, is gradually becoming more favorable in many regions, facilitating market access and encouraging further investment in the sector. North America currently dominates the market, followed by Europe and Asia-Pacific, with these regions expected to maintain significant growth throughout the forecast period. However, emerging markets in the Middle East, Africa, and South America present considerable future potential as regulations evolve and public perception shifts. Competition within the industry is fierce, with established pharmaceutical companies and emerging cannabis-focused businesses vying for market share. This competitive landscape fosters innovation and drives the development of high-quality, effective products. The continued growth trajectory hinges on several factors. Further scientific validation of medical cannabis's efficacy across a broader range of conditions will solidify its position in mainstream healthcare. Additionally, overcoming persistent regulatory hurdles and stigma associated with cannabis remains crucial for broader adoption. Effective public education campaigns addressing safety concerns and responsible use will play a key role in fostering growth. Innovation in delivery methods and formulations, potentially leading to more precise dosing and improved patient outcomes, will further propel market expansion. The successful integration of medical cannabis into existing healthcare systems and insurance coverage will also significantly influence the market's trajectory. While challenges remain, the overall outlook for the medical cannabis market remains strongly positive, indicating substantial opportunities for growth and investment in the years to come. Recent developments include: In March 2024, Jesse Ventura introduced a cannabis edible brand. Ventura partnered with Retro Bakery, based in Columbia Heights, to manufacture THC edibles derived from hemp., February 2023: Metrc reported the expansion of its contract with the State of Missouri to support the regulation of its adult-use cannabis market.. Key drivers for this market are: Increasing Number of Countries Legalizing the Use of Medical Marijuana, Trend of Producing Edible Products with Cannabis; Favorable Reimbursement Environment and Government Support in Certain Countries. Potential restraints include: Increasing Number of Countries Legalizing the Use of Medical Marijuana, Trend of Producing Edible Products with Cannabis; Favorable Reimbursement Environment and Government Support in Certain Countries. Notable trends are: The Chronic Pain Segment is Expected to Experience the Fast Growth Over the Forecast Period.

Global Medical Marijuana Market is estimated to reach USD 23.5 billion by 2024, registering a CAGR of 25% during the forecast period 2020-2026. Use of marijuana in treatment of arthritis, effectiveness in treatment for neuropathic pain, growing demand for medical marijuana legalization and production of edible products with cannabis are driving the market growth.
The market size reveals a high growth as there is a booming demand for marijuana for therapeutic applications. Rise in prevalence of dreaded diseases is likely to trigger the market growth in the forecast period.

Medical Marijuana Market Trends, Drivers and Opportunities:

Marijuana more commonly called as medical cannabis is enabling a high industry growth as there have been substantial investments by the pharmaceutical companies in the development of cannabis products and devices. The plant contains around 800 chemicals that can be used for various medicinal purposes. Health conscious consumers with access to these products are now enjoying its benefits. With the legalization of marijuana, physicians are now interestingly employing cannabis for understanding the potency of treatments. For instance, with the legalization of cannabis in the U.S. it has minimized the dependency on opiods and description drugs.
In Europe, cannabis is an illegal drug which mainly attracts a polarized debate between public and politicians. However, with the rising interest, it now addresses some complex issues leading in modifying the stringent policies for medical use of marijuana.
Rise in use of marijuana for therapeutic purpose owing to rise in medical conditions in the geriatric population. In addition, the market witness an increasing potential of marijuana throughout the forecast period. In addition, several countries have legalized the use of marijuana for medical purpose to treat chronic diseases and passed laws that strengthens its purpose.
The market witness trends such as rise in adoption of cannabis for Parkinson’s, Alzheimer’s and Arthritis disease. Moreover, the presence of large pool of patients and legalization of marijuana in developed countries is likely to propel the demand. On contrary, restraints such as limited production and less knowledge of extraction of marijuana for medical applications is likely to confine the market growth throughout the forecast period.

Medical Marijuana Market Segment Insights:

By Application:

Based on application, the medical marijuana market can be segmented into anorexia seizures, muscle spasms and pain management. Muscle spams and pain management are likely to witness a significant market share due to rising prevalence of chronic disorders in geriatric and child population.

Based on Distribution Channel:

Based on distribution channel, the medical marijuana market can be segmented into dispensaries and online. Dispensaries accounted for the largest market share in 2018 accounting for a major revenue share and rise in patient influx.

By Route of Administration:

Based on the route of administration, the market can be segmented into oral, tropical and inhalation. Inhalation category accounted for a significant market share owing to several advantages such as rise in adoption of cannabis and effective regulations pertaining to the use of marijuana for medical purpose.

By Geographical:

Based on geographical segmentation, the market can be segmented into North America, South America, Europe, Asia Pacific, Middle-East and Africa. North America dominated the global market in 2018 and is anticipated to exhibit a higher CAGR due to extensive use of marijuana for medical applications. In the U.S. marijuana is permitted for medical use and applications. Also, increasing research and development for medical purpose supplements the U.S. market growth throughout the forecast period.

Competitive Landscape:

Some of the key players mentioned in the medical marijuana market report are Canopy Growth, Aurora Cannabis Inc., Aphria Inc., GW Pharmaceuticals, Emerald Health Therapeutics, MedReleaf Corporation, Tilray and Medical Marijuana, Inc. The vendors have adopted strategies such as spending on research and development activities, production of novel drugs and strategic collaboration.

The North America Legal Marijuana Market size was valued at USD 15.9 billion in 2023 and is projected to reach USD 42.29 billion by 2032, exhibiting a CAGR of 15.0 % during the forecasts period. North America marijuana market also includes the growth, supply, and use and sale of marijuana for medical and recreational purposes due to emerging legislation. The medicinal cannabis is used in the treatment of chronic pain, anxiety, and other ailments; while the legalization of cannabis is enjoying increased acceptance for the use in recreational activities among adults. The market consists of varieties of products such as dried flower, oils, edibles and topicals. These trends are the further state-level legalization, the rising customers’ concern over quality and potency, and the improvement in the field of plant growing. The market is still relatively young, however the desire for this kind of energy storage continues to grow and with increased business interest will come increased legislative interest.

The size of the Legal Marijuana Market market was valued at USD 26.0 billion in 2023 and is projected to reach USD 128.92 billion by 2032, with an expected CAGR of 25.7 % during the forecast period. As for The Legal Marijuana Market, it refers to the cannabis market that covers legalization and purchase of marijuana and products derived there from within recognized legal and permitted areas. This market contains both the medicinal and adult use potencies for ailments such as chronic pain and for recreational and lifestyle use. The major trends include progressively legalization across the regions, enhanced investment towards cannabis research, and advanced products such as edibles and concentrates, and wellness supplements. The market is also growing due to social factors such as shift in culture, technology for improved farming practices and increased use of medical marijuana and marijuana for recreational use. The status of the markets remain dynamic as key drivers for the markets such as regulatory requirements and more importantly shifts in the market consumption trends persist to influence market status. Recent developments include: In January 2024, Village Farms International, Inc., announced the launch of two cannabis brands in the UK, such as Pure Sunfarms and The Original Fraser Valley Weed Co. (Fraser Valley). 4C LABS, a UK-based medical cannabis company, will distribute these brands. , In March 2023, Canopy Growth introduced six new beverage flavors. Under the Deep Space brand, the company announced Canada's first cannabis-infused beverage with naturally occurring caffeine. The company also launched four flavors under the Tweed brand for springtime. .